Instructor in Medicine, Brigham and Women's Hospital

Allergy & Immunology

Dr. David E. Sloane, MD


Doctor David E. Sloane, MD is an expert in the field of Allergy & Immunology. He researched medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received awards:"Meaningful Use Stage 1 Certification". David Sloane is also a published doctor. He has 11 paper published. The most recent paper is: Autoimmune progesterone dermatitis: clinical presentation and management with progesterone desensitization for successful in vitro fertilization. He is registered with Medicare and accepts Medicare payments.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1164403119
NPPES Provider LastName   SLOANE
NPPES Provider FirstName   DAVID
NPPES Provider ZIPCode   024672477
NPPES Provider State   MA
Specialty Description   Allergy/Immunology
Total Claim Count   416.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1164403119
Last Name Of The Provider SLOANE
First Name Of The Provider DAVID
View All

Similar Doctors


Dr. Matthew C. Altman, MD
This Doctor is OpenDoctor Recommended.
Dr. Timothy T. Kyin, MD
This Doctor is OpenDoctor Recommended.
Dr. Arthur R. Rabson, MD
Dr. Sunil S. Nair, MD
This Doctor is OpenDoctor Recommended.
Dr. Leigh H. Simmons, MD
This Doctor is OpenDoctor Recommended.
Dr. Li Tso, MD
This Doctor is OpenDoctor Recommended.
Dr. Aleena Banerji, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Daniel G. Steinberg, MD
This Doctor is OpenDoctor Recommended.
Dr. Sachin N. Baxi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Beth A. Schaff, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog